SOX30

Across TCGA pan-cancer cohorts, SOX30 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SOX30 data layer compared with 26 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher SOX30 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated SOX30 expression acts as an unfavorable survival marker, although some lineages such as HNSC and CCRCC show a favorable association.

HNSC and CCRCC are the cancer types where SOX30 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	III,IV	1.000	0.618	.009	12	view →
CCRCC	DFS	Median	All	1.000	0.389	.040	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

SOX30–HNSC (DFS)

Open the HNSC breakdown →